A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(6 sites)

United States

Children's Hospital of Orange County, Orange, California

Nemours Childrens Health, Jacksonville, Jacksonville, Florida

Wichita Urology Group, Wichita, Kansas

Childrens Hospital New Orleans, New Orleans, Louisiana

Albany Medical College, Albany, New York

Duke University Medical Center, Durham, North Carolina